Surgical outcomes for hepatocellular carcinoma detected after hepatitis C virus eradiation by direct‐acting antivirals (original) (raw)
The Impact of Direct-Acting Antiviral Therapy on the Risk of Recurrence after Curative Resection in Patients with Hepatitis-C-Virus-Related Early Stage Hepatocellular Carcinoma
Ching-Hui Chuang
Medicina, 2022
View PDFchevron_right
Low Hepatitis C Viral Load Predicts Better Long-Term Outcomes in Patients Undergoing Resection of Hepatocellular Carcinoma Irrespective of Serologic Eradication of Hepatitis C Virus
Kiyoshi Hasegawa
Journal of Clinical Oncology, 2013
View PDFchevron_right
Hepatitis C Virus Cure Rates Are Reduced in Patients With Active but Not Inactive Hepatocellular Carcinoma: A Practice Implication
Akihiro Tamori
Clinical Infectious Diseases, 2019
View PDFchevron_right
Response rates to direct antiviral agents among hepatitis C virus infected patients who develop hepatocellular carcinoma following direct antiviral agents treatment
Hepatoma Research
Hepatoma Research, 2020
View PDFchevron_right
The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment
Shinya Maekawa
Internal Medicine
View PDFchevron_right
Surgical Outcomes in Hepatitis C Virus-Related Hepatocellular Carcinoma: Special Reference to Sustained Virological Responses to Interferon Therapy
Akihiro Tamori
American Surgeon, 2017
View PDFchevron_right
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV‐TARGET Analysis
Lucy Akushevich
Hepatology Communications, 2019
View PDFchevron_right
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis
Daniele Nicolini
Digestive and Liver Disease
View PDFchevron_right
Improved survival of patients with hepatocellular carcinoma and compensated hepatitis C virus-related cirrhosis who attained sustained virological response
luigi roffi
Liver international : official journal of the International Association for the Study of the Liver, 2017
View PDFchevron_right
Accelerated hepatocellular carcinoma recurrence rate after postoperative direct-acting antivirals treatment – preliminary report
Dariusz Wasiak
Clinical and Experimental Hepatology
View PDFchevron_right
De-novo versus recurrent hepatocellular carcinoma following direct-acting antiviral therapy for hepatitis C virus
Mohamed Nabil
European journal of gastroenterology & hepatology, 2017
View PDFchevron_right
Rates of Hepatocellular Carcinoma After Start of Treatment for Chronic Hepatitis C Remain High with Direct Acting Antivirals: Analysis from a Swiss Liver Transplant Center
Stefanie von Felten
Journal of Hepatocellular Carcinoma, 2021
View PDFchevron_right
Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals
Javid Fazili
Cureus, 2018
View PDFchevron_right
Hepatitis C Antiviral Therapy In Patients With Successfully Treated Hepatocellular Carcinoma: Dancing With Wolves
Mohamed El-Kassas
Journal of Hepatocellular Carcinoma, 2019
View PDFchevron_right
Frequency of De Novo Hepatocellular Carcinoma after Direct-acting Antiviral Therapy for Chronic Hepatitis C: A Prospective Follow-up
Aneeqa Ahmad
Euroasian Journal of Hepato-Gastroenterology
View PDFchevron_right
The short-term incidence of hepatocellular carcinoma is not increased after hepatitis C treatment with direct-acting antivirals: An ERCHIVES study
Darrick Li
Hepatology (Baltimore, Md.), 2017
View PDFchevron_right
Eradication of Hepatitis C Virus Reduces the Risk of Hepatocellular Carcinoma in Patients with Compensated Cirrhosis
Rui Marinho
Digestive Diseases and Sciences, 2011
View PDFchevron_right
Direct-acting antiviral therapy decreases hepatocellular carcinoma recurrence rate in cirrhotic patients with chronic hepatitis C
Joseph koffi DOKPO
Liver international : official journal of the International Association for the Study of the Liver, 2017
View PDFchevron_right
A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C-Associated Liver Cirrhosis
Soo Aleman
Clinical Infectious Diseases, 2013
View PDFchevron_right
Direct acting antivirals treatment for hepatitis C virus infection does not increase the incidence of de novo hepatocellular carcinoma occurrence
Ivan Gentile
Medicine
View PDFchevron_right
SAT-229-Risk of hepatocellular carcinoma in patients with chronic hepatitis C and stage-3 liver fibrosis after sustained virological response with direct acting antivirals
Conrado Rodriguez
Journal of Hepatology, 2019
View PDFchevron_right
Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients
Wan-long Chuang
Scientific reports, 2017
View PDFchevron_right
Predictors of Recurrence in Hepatitis C Virus Related Hepatocellular Carcinoma after Hepatic Resection: A Retrospective Cohort Study
Ahmed Shehta
The Eurasian Journal of Medicine, 2014
View PDFchevron_right
Long-Term Risk of Hepatocellular Carcinoma Following Direct-Acting Antiviral Therapy in Compensated Liver Cirrhosis Induced by Hepatitis C Virus Infection
Corina Ursulescu
Hepatitis Monthly
View PDFchevron_right
Impact of treating chronic hepatitis C infection with direct-acting antivirals on the risk of hepatocellular carcinoma: The debate continues – A mini-review
Mohamed El-Kassas
Journal of Advanced Research, 2019
View PDFchevron_right
Hepatocellular carcinoma recurrence in hepatitis C virus-related cirrhosis treated with direct-acting antivirals
xavier adhoute
European Journal of Gastroenterology & Hepatology, 2018
View PDFchevron_right
Increased incidence or recurrence of hepatocellular carcinoma in hepatitis C virus cirrhotic patients treated with direct-acting antivirals: myth or fact?
Giuseppe Cabibbo
Expert Review of Anticancer Therapy, 2018
View PDFchevron_right
Hepatocellular carcinoma after treatment of hepatitis C with direct-acting antivirals: a critical re-appraisal
Ioannis Tsomidis, Elias Kouroumalis, Hepatoma Research
Hepatoma Research, 2023
View PDFchevron_right
Hepatocellular carcinoma in long-term sustained virological responders following antiviral combination therapy for chronic hepatitis C
Katharina Staufer
Journal of Viral Hepatitis, 2008
View PDFchevron_right
Recurrence rate of hepatocellular carcinoma in patients with treated hepatocellular carcinoma and hepatitis C virus-associated cirrhosis after ombitasvir/paritaprevir/ritonavir+dasabuvir+ribavirin therapy
Carmen Preda
United European Gastroenterology Journal
View PDFchevron_right
Improved Long-term Survival after Liver Resection for Hepatocellular Carcinoma in the Modern Era: Retrospective Study from HCV-endemic Areas
Masayuki Ohta
World Journal of Surgery, 2006
View PDFchevron_right
A Comparison of Prognosis between Patients with Hepatitis B and C Virus-related Hepatocellular Carcinoma Undergoing Resection Surgery
Jaw-ching Wu
World Journal of Surgery, 2011
View PDFchevron_right
Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinoma
Mark Schmidt
Journal of viral hepatitis, 2016
View PDFchevron_right